EcoDrugPlus

Mcl1 Apoptosis Regulator, Bcl2 Family Member B

Ensembl ID : ENSBSLG00000017242
Gene Symbol: MCL1B
1 Cross references
171 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSBSLG00000023797
Gene Symbol: MDM2
3 Cross references
280 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSBSLG00000015170
Gene Symbol: MET
3 Cross references
204 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSBSLG00000023673
Gene Symbol: MLST8
3 Cross references
195 Possible Orthologues:

Nad(P)h Quinone Dehydrogenase 1

Ensembl ID : ENSBSLG00000010372
Gene Symbol: NQO1
3 Cross references
180 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSBSLG00000023210
Gene Symbol: NPC1L1
3 Cross references
190 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSBSLG00000009153
Gene Symbol: LOC114864446
3 Cross references
194 Possible Orthologues:

P2y Purinoceptor 12-Like

Ensembl ID : ENSBSLG00000009277
Gene Symbol: LOC114868557
3 Cross references
182 Possible Orthologues:

Phd Finger Protein Rhinoceros-Like

Ensembl ID : ENSBSLG00000004351
Gene Symbol: LOC114870271
2 Cross references
179 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSBSLG00000014057
Gene Symbol: PIM3
3 Cross references
196 Possible Orthologues:

Rac-Beta Serine/threonine-Protein Kinase

Ensembl ID : ENSBSLG00000011096
Gene Symbol: LOC114868391
3 Cross references
199 Possible Orthologues:

Rac-Beta Serine/threonine-Protein Kinase-Like

Ensembl ID : ENSBSLG00000007175
Gene Symbol: LOC114869279
3 Cross references
185 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).